Effects of adenoviral-mediated coexpression of bone morphogenetic protein-7 and insulin-like growth factor-1 on human periodontal ligament cells

Journal of Periodontal Research

Volumn 45, Issue 4, 2010, Pages 532-540

  Yang, L ^a   Zhang, Y ^a   Dong, R ^a   Peng, L ^a   Liu, X ^a   Wang, Y ^a   Cheng, Xiangrong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 7; Human periodontal ligament cell; Insulin like growth factor 1; Recombinant adenovirus

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BMP7 PROTEIN, HUMAN; COLLAGEN TYPE 1; COLORING AGENT; DIAGNOSTIC AGENT; OSTEOGENIC PROTEIN 1; RUNX2 PROTEIN, HUMAN; SOMATOMEDIN C; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR RUNX2;

ADENOVIRUS; ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CULTURE TECHNIQUE; CYTOLOGY; ESCHERICHIA COLI; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HUMAN; MOUSE; PATHOLOGY; PERIODONTAL LIGAMENT; PHYSIOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TISSUE ENGINEERING; TRANSGENE; UPREGULATION;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 7; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; COLLAGEN TYPE I; COLORING AGENTS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; OSTEOGENESIS; PERIODONTAL LIGAMENT; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TETRAZOLIUM SALTS; THIAZOLES; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFECTION; TRANSGENES; UP-REGULATION;

EID: 77954856587     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01268.x     Document Type: Article

References (45)

1. Kocher TKJ, Dzierzon U, Sawaf H, Plagmann HC. Disease progression in periodontally treated and untreated patients - a retrospective study. J Clin Periodontol 2000, 27:866-872.
2. Taba MJQ, Sugai JV, Giannobile WV. Current concepts in periodontal bioengineering. Orthod Craniofac Res 2005, 8:292-302.
3. Helder MN, Karg H, Bervoets TJ. Bone morphogenetic protein-7 (osteogenic protein-1, OP-1) and tooth development. J Dent Res 1998, 77:545-554.
4. Giannobile WV, Ryan S, Shih MS, Su DL, Kaplan PL, Chan TC. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol 1998, 69:129-137.
5. Rutherford RB, Sampath TK, Rueger DC, Taylor TD. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992, 7:297-301.
6. van den Bergh JP, ten Bruggenkate CM, Groeneveld HH, Burger EH, Tuinzing DB. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol 2000, 27:627-636.
7. O'Connor R. Survival factors and apoptosis. Adv Biochem Eng Biotechnol 1998, 62:137-166.
8. Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ. Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 1992, 63:515-525.
9. Han X, Amar S. IGF-1 signaling enhances cell survival in periodontal ligament fibroblasts vs. gingival fibroblasts. J Dent Res 2003, 82:454-459.
10. Chen FM, Zhao YM, Wu H. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release 2006, 114:209-222.
11. Yeh LC, Adamo ML, Olson MS, Lee JC. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 1997, 138:4181-4190.
12. Yeh LC, Lee JC. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 2006, 1763:57-63.
13. Chubinskaya S, Hakimiyan A, Pacione C. Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 2007, 15:421-430.
14. Loeser RF, Pacione CA, Chubinskaya S. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 2003, 48:2188-2196.
15. Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003, 74:202-213.
16. Dunn CA, Jin Q, Taba M, Franceschi RT, Bruce Rutherford R, Giannobile WV. BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther 2005, 11:294-299.
17. Zhang Y, Wang Y, Shi B, Cheng X. A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. Biomaterials 2007, 28:1515-1522.
18. Murakami Y, Kojima T, Nagasawa T, Kobayashi H, Ishikawa I. Novel isolation of alkaline phosphatase-positive subpopulation from periodontal ligament fibroblasts. J Periodontol 2003, 74:780-786.
19. Fujii S, Maeda H, Wada N, Tomokiyo A, Saito M, Akamine A. Investigating a clonal human periodontal ligament progenitor/stem cell line in vitro and in vivo. J Cell Physiol 2008, 215:743-749.
20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95:2509-2514.
21. Miller AG, Aplin JD, Westwood M. Adenovirally mediated expression of insulin-like growth factors enhances the function of first trimester placental fibroblasts. J Clin Endocrinol Metab 2005, 90:379-385.
22. Kobayashi M, Takiguchi T, Suzuki R. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament. J Dent Res 1999, 78:1624-1633.
23. Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954, 7:322-326.
24. Peng L, Cheng X, Wang J, Xu D, Wang G. Preparation and evaluation of porous chitosan/collagen scaffolds for periodontal tissue engineering. J. Bioact. Compat. Polym. 2006, 21:207-220.
25. Nakahara T. A review of new developments in tissue engineering therapy for periodontitis. Dent Clin North Am 2006, 50:265-276. ix-x
26. Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist 2002, 7:46-59.
27. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998, 80:35-47.
28. Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem 2005, 74:711-738.
29. Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004, 9:519-526.
30. Zhu Z, Lee CS, Tejeda KM, Giannobile WV. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res 2001, 80:892-897.
31. Mountford PS, Smith AG. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 1995, 11:179-184.
32. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000, 1:376-382.
33. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 1984, 39:449-467.
34. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991, 11:5848-5859.
35. Dirks W, Wirth M, Hauser H. Dicistronic transcription units for gene expression in mammalian cells. Gene 1993, 128:247-249.
36. Ziros PG, Gil AP, Georgakopoulos T. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 2002, 277:23934-23941.
37. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007, 41:462-473.
38. Rutherford RB, Racenis P, Fatherazi S, Izutsu K. Bone formation by BMP-7-transduced human gingival keratinocytes. J Dent Res 2003, 82:293-297.
39. Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007, 59:339-359.
40. Seol YJ, Lee JY, Park YJ. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 2004, 26:1037-1041.
41. Bumgardner JD, Wiser R, Gerard PD. Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym Ed 2003, 14:423-438.
42. Shin SY, Park HN, Kim KH. Biological evaluation of chitosan nanofiber membrane for guided bone regeneration. J Periodontol 2005, 76:1778-1784.
43. Arpornmaeklong P, Suwatwirote N, Pripatnanont P, Oungbho K. Growth and differentiation of mouse osteoblasts on chitosan-collagen sponges. Int J Oral Maxillofac Surg 2007, 36:328-337.
44. Arpornmaeklong P, Pripatnanont P, Suwatwirote N. Properties of chitosan-collagen sponges and osteogenic differentiation of rat-bone-marrow stromal cells. Int J Oral Maxillofac Surg 2008, 37:357-366.
45. Zhang Y, Cheng X, Wang J. Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun 2006, 344:362-369.